ABSTRACT
The prevention and treatment of secondary spinal injury remain controversial in spite of several experimental and clinical studies. [2] [3] [4] [5] [6] Currently, steroid treatment after SCI remains a viable option although some studies reported that steroids might not be beneficial and actually increase the overall rate of complications and even may bring about death. [7] [8] [9] [10] The primary aim of the present study is to evaluate the potential effects of intravenous methylprednisolone treatment on the neurological outcome of SCI patients which have thoracolumbar junction spine fractures.
INTRODUCTION
Although spinal cord injury (SCI) is a serious and common health problem, the effective management of these types of injuries remains controversial. Mechanical compression, impact and shear injuries cause a primary SCI which initiates a cascade of deleterious pathological processes and leads to secondary neurological tissue destruction. Both primary and secondary injury mechanisms give rise to subsequent neurological deterioration. [1] Surgical procedures, such as decompression and stabilization of the spine, are primarily intended to prevent increased pressure within the spinal canal and to restore normal spinal alignment. Although decompression of the spinal cord is fundamental, it may not prevent the spinal cord from secondary injury. [1] Cite this article as: İlik MK, Keskin F, Erdi F, Kaya B, Karataş Y, Kalkan E. The effects of steroids in traumatic thoracolumbar junction patients on neurological outcome. Ulus Travma Acil Cerrahi Derg 2019;25:484-488.
MATERIALS AND METHODS
The medical records and patient charts of our 182 SCI patients who were sustained an injury at the thoracolumbar junction (T10-L1) between September 2008 and January 2015 were analyzed retrospectively. All of these patients were isolated SCI patients who were operated by us within 24 hours after the development of traumatic SCI. The patients who had additional injuries, such as head trauma, thorax trauma, visceral organ injury, or an unstable clinical-biochemical profile, were excluded from the study group in this research.
In our clinic, we routinely started methylprednisolone treatment to SCI patients according to the NASCIS II protocol [2] until 2011, but then we gave up this medication after novel findings that indicated severe side effects of methylprednisolone treatment. [11] The patients divided into two groups: In group 1, there were 95 patients (60 male and 35 female) who received methylprednisolone treatment in conjunction with early surgical intervention. In group 2, there were 87 patients (56 male, 31 female) who underwent only early surgical intervention without methylprednisolone treatment. All patients in this study were admitted to our clinic within eight hours after the development of traumatic SCI.
The methylprednisolone treatment was administered to group 1 patients according to the NASCIS II protocol. [2] Briefly, methylprednisolone was intravenously administered in a bolus dose (30 mg/kg) and then in maintenance dose was administered as (5.4 mg/kg/h) over 23 hours.
All patients were operated by the same experienced spinal surgery team and underwent rehabilitation at the same physical medicine and rehabilitation center.
All patients underwent a neurological examination during their admission at our emergency service, and their neurological status was categorized into classes A-D according to the criteria established by the American Spinal Injury Association (ASIA) motor index score. Patients with an ASIA motor index score of E were excluded from this study.
All patients were re-evaluated at the last follow-up and their initial and the last follow-up ASIA scores were compared.
Demographic data, initial and the last follow-up ASIA scores, performed surgical procedures were summarized in Table 1 .
Surgical Treatment
We aimed to maintain the stability and decompression of the spinal cord in a standard manner in all patients. Eightyeight patients in group 1 operated with a posterior approach, four patients operated with an anterior approach, and three patient from group 1 operated by a combined posterior/anterior approach. Eighty-two patient from group 2 operated with a posterior approach, two patient from group 2 operated with an anterior approach, and three patients operated with a combined posterior/anterior approach. The decom- pression and fusion procedures were conducted in a standard manner for all patients.
Spinal decompression was achieved via discectomy, corpectomy, osteotomy and total laminectomy. Transpedicular screws and cages were used in conjunction with autografts and allografts to establish stabilization and fusion. In group 1, eight dural tears occurred during surgery, which were repaired by primary saturation with fibrin glue. In group 2, the dural tear occurred in seven patients, which were repaired as group 1.
After surgery, all patients were fitted with a thoracolumbar brace for eight weeks and referred to the same rehabilitation center within the shortest time interval. All patients in this study underwent rehabilitation at the same physical medicine and rehabilitation center according to their neurological status.
At the last follow-up, all patients were re-evaluated, and their neurological status was assessed according to ASIA classification.
During the follow-up period, some complications, such as decubitus ulcers, deep vein thrombosis, urinary tract infections, were developed in both groups. Encountered complications were summarized in Table 2 .
The patients with decubitus ulcers were consulted with plastic reconstructive surgery and after adequate treatment, their decubitus ulcers resolved. Deep vein thrombosis, gastrointestinal bleeding, and uriner tract infection were treated with medical treatment.
Mortality did not occur in these series.
Statistical Analysis
Statistical analysis was performed using Independent Sample 
RESULTS
In this study, two groups of the patients were comparable in terms of the number, age and sex. The mean time interval between the trauma and operation was not statistically significant (p<0.05) among the groups and 14.6±4.3 hours in group 1 and 13.3±3.5 hours in group 2.
ASIA scores of the patients were similar between groups at admission and the one-year follow-up examination without any significant statistically difference (p>0.05).
Mean complication rate was statistically significantly high in group 1 who underwent steroid treatment after surgery (p=0.01).
The results obtained in this study were summarized in Table 3 .
DISCUSSION
SCI is a severe public health problem. Neuronal injury occurs via primary and secondary injury mechanisms during SCI. [12, 13] Primary injuries that arise from compression, impact, and shear initiate secondary processes that result in damage characterized by inflammation, ischemia, edema, electrolyte disturbances, free oxygen radicals, apoptosis, and demyelination. [12] [13] [14] [15] [16] Primary injury tends to be unavoidable following a trauma, but if the secondary injuries can be blocked or mitigated, then, the neurological function may be spared or treated. [16] Various experimental pharmacological agents have been used over the past 30 years to prevent secondary injury in various animal studies but, of these agents, only methylprednisolone has been widely used in daily clinical practice. [3] [4] [5] [17] [18] [19] Exper- Table 3 . Neurological state initial and the last follow-up in both groups imental studies have demonstrated that methylprednisolone reduces inflammation, attenuates the production of free radicals, and decreases lipid peroxidation. Additionally, methylprednisolone increases Na+/K+-ATPase activity and promote local blood supply and perfusion. [20] [21] [22] [23] Methylprednisolone shows some neuroprotective effects due to its antioxidant properties. Methylprednisolone decreases tumor necrosis alpha synthesis, increases blood flow to the spinal cord, decreases calcium accumulation, decreases posttraumatic axonal injury and lipid peroxidation. [24] We should note that although methylprednisolone has some beneficial effects, it also has significant side effects, [25] particularly high dose methylprednisolone after SCI increases the risk of wound infection, pneumonia, sepsis, gastrointestinal hemorrhage, pulmonary injury and may lead to even death. [25, 26] Among the clinical trials that aimed to evaluate the NASCIS II and NASCIS III protocols, Bracken et al. [2] [3] [4] [5] reported that methylprednisolone treatment improved neurological function but increased the probability of infection. However, other clinical studies indicated that the NASCIS II protocol did not produce any beneficial effects on neurological function. [27] [28] [29] In our clinic, we routinely started methylprednisolone treatment to SCI patients according to the NASCIS II protocol [2] until 2011, but then we gave up this medication after novel findings that indicated severe side effects of methylprednisolone treatment. [15] In this study, we evaluate the potential effects of intravenous methylprednisolone treatment on the neurological outcome of SCI patients which have thoracolumbar junction spine fractures. According to our results, steroids have no significant beneficial effects on the neurological outcome of SCI patients but have significant side effects and leads to increased complication rates.
The primary limitation of the present study is its retrospective nature. However, the findings obtained in this study may contribute to the awareness about the significant side effects of steroids in this patient group.
Conclusion
Steroids have no significant beneficial effects on the neurological outcome of SCI patients but have significant side effects and lead to increased complication rates.
